ISSN: 2148-8274 / E-ISSN: 2587-0084
, Türk Üreme Tıbbı ve Cerrahisi
Dergisi

Turkish Journal of Reproductive Medicine and Surgery

Dernek Sitesi
Kayıtlı İndexler
ORİJİNAL ARAŞTIRMALAR

Histerektomi Materyalinde Adenomyozis Saptanan Hastalarla Diğer Benign Patolojilerin Saptandığı Hastaların Karşılaştırılması: Retropektif Çalışma
Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study
Received Date : 27 Nov 2023
Accepted Date : 27 Mar 2024
Available Online : 02 May 2024
Doi: 10.24074/tjrms.2023-100472 - Makale Dili: EN
Turkish Journal of Reproductive Medicine and Surgery. 2024;8(2):54-62.
ÖZET
Amaç: Adenomiyozisin risk faktörlerinin analizi, etiyolojiye ait nedenlerin etkilerini değerlendirmede yararlı olabilir. Çalışmamızın amacı benign jinekolojik nedenlerle opere edilen hastalarda, histerektomi materyalinde Adenomyozis saptanan hastalarla diğer benign patolojilerin saptandığı hastaların risk faktörlerinin karşılaştırılmasıdır. Gereç ve Yöntemler: Adenomyozis risk faktörlerinin rolünü analiz etmek için Ocak 2019 ile Kasım 2022 tarihleri arasında hastanemizde histerektomi yapılan 352 kadının verilerini retrospektif olarak değerlendirdik. Tüm olguların tanısı postoperatif histopatalojik incelemeye göre konuldu. Bulgular: Sigara kullanımı, Mirena®, parite sayısı, ilk gebelik yaşı, kürtaj varlığı, dismenore, mens şiddeti, disparoni, intermenstrual pelvik ağrı ve doğum tipi ile adenomyozis varlığı arasında istatistiksel bazda anlamlıxbir ilişki mevcuttur (p<0.05). Sigara içmeyen ve 5 yıldan az sigara içenlerde adenomyozis varlığı oransal olarak daha yüksek saptanmıştır. İlk gebelik yaşı (25-30) ve ilk adet görme yaşı (>14) olan kadınlarda adenomyozis varlığı orantısal olarak daha yüksek bulunmuştur. Dismenore, Disparoni varlığında ve sezaryen geçiren kadınlarda adenomyozis varlığı orantısal olarak daha yüksek bulundu. Mirena® kullanan kadınlarda adenomyozis varlığı oransal olarak daha yüksek bulundu. Sonuç: Adenomyozis semptomları nedeniyle önemli bir hasta grubunda yaşam kalitesini olumsuz etkilemektedir. Bu semptomlar nedeniyle yapılan histerektomi operasyonları sonrasında yüksek oranda saptanan adenomyozis bu konuda daha fazla çalışmaya ihtiyaç duyulduğunu göstermektedir.
ABSTRACT
Objective: Analysis of the risk factors of adenomyosis may be useful in evaluating the effects of etiologic factors. The aim of our research is to compare the risk factors of individuals who were operated on for benign gynecological reasons, patients with Adenomyosis detected in the hysterectomy material, and patients with other benign pathologies. Material and Methods: To make an analysis on the role of risk variables for adenomyosis, we retrospectively evaluated theidata of 352 women who had hysterectomy iniour hospital at the interval of January 2019 - November 2022. All cases were diagnosed according to postoperative histopathologic examination. Results: Smoking, Mirena®, number of parities, age at first pregnancy, presence of dilation and curettage, dysmenorrhea, menstrual intensity, dyspareunia, intermenstrual pelvic pain, and delivery type were substantially correlated with adenomyosis (p<0.05). Accordingly, the existence of adenomyosis was proportionally higher in non-smokers, <5 years smokers. Accordingly, the existence of adenomyosis was observed to be proportionally greater in females with the age at first pregnancy (25-30) and age at menarche (>14). Accordingly, the existence of adenomyosis was observed to be proportionally higher in females with dysmenorrhea, dyspareunia, and cesarean section. Accordingly, the existence of adenomyosis was shown to be proportionally higher in females with Mirena®. Conclusion: Because of its symptoms, adenomyosis has a detrimental effect on a sizeable portion of patients' quality of life. Further research in this area is required, as evidenced by the high prevalence of adenomyosis seen following hysterectomy procedures carried out as a result of these symptoms.
REFERANSLAR
  1. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility:a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update 2012;18(4):374-92. [Crossref]  [PubMed] 
  2. Zaloudek C, Hendrickson MR. Mesenchymal tumors of the uterus. Blausteins' pathology of the female genital tract. Kurman RJ ed. 5th edition, New York: Springer-Verlag, New York, 2002. p. 561-73
  3. Levy G, Dehaene A, Laurent N, Lernout M, et al. An update on Adenomyosis. Diagnostic and Interventional Imaging. 2013;94(1):3-25. [Crossref]  [PubMed] 
  4. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am. 1989;16(1):221-35. [Crossref]  [PubMed] 
  5. Bazot M, Fiori O, Darai E. Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod. 2006;21(4):1101-2; author reply 1102-3. [Crossref]  [PubMed] 
  6. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod. 2005;20(8):2309-16. [Crossref]  [PubMed] 
  7. Benagiano G, Brosens I. The endometrium in adenomyosis. Womens Health (Lond). 2012;8(3):301-12. [Crossref]  [PubMed] 
  8. Atri M, Reinhold C, Mehio AR, Chapman WB, Bret PM. Adenomyosis: US features with histologic correlation in an in-vitro study. Radiology. 2000;215 (3):783-90. [Crossref]  [PubMed] 
  9. Gonzalez M, de Mattos L, Gonc¸ Alves M, et al. Patients with Adenomyosis are more likely to have deep endometriosis. Gynecol Surg 2012; [Link] 
  10. Antero MF, Ayhan A, Segars J, Shih IM. Pathology and Pathogenesis of Adenomyosis. Semin Reprod Med. 2020;38(2-03):108-18. [Crossref]  [PubMed]  [PMC] 
  11. Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):465-77. [Crossref]  [PubMed] 
  12. Li X, Liu X, Guo SW. Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy. J Obstet Gynaecol Res. 2014;40(2):485-94. [Crossref]  [PubMed] 
  13. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009;280(4):529-38. [Crossref]  [PubMed]  [PMC] 
  14. Curtis KM, Hillis SD, Marchbanks PA, Peterson HB. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol. 2002;187(3):543-4. [Crossref]  [PubMed] 
  15. Parkar W, Meekins JW, Nicol A. Adenomyosis following endometrial resection--a retrospective study. J Obstet Gynaecol. 1998;18(6):564-5. [Crossref]  [PubMed] 
  16. Brosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: are the changes of clinical significance? Reprod Biomed Online. 2012;24(5):496-502. [Crossref]  [PubMed] 
  17. Mehasseb MK, Taylor AH, Pringle JH, Bell SC, Habiba M. Enhanced invasion of stromal cells from adenomyosis in a three-dimensional coculture model is augmented by the presence of myocytes from affected uteri. Fertil Steril. 2010;94(7):2547-51. [Crossref]  [PubMed] 
  18. Chantalat E, Valera MC, Vaysse C, Noirrit E, Rusidze M, Weyl A, et al. Estrogen Receptors and Endometriosis. Int J Mol Sci. 2020;21(8):2815. [Crossref]  [PubMed]  [PMC] 
  19. Zaloudek C, Norris J. Mesenchymal tumours of the uterus. Blaunstein's Pathology of the Female Genital Tract. 3rd edn. Springer Verlag, New York, 1987. p. 374. [Crossref] 
  20. Mishra I, Melo P, Easter C, Sephton V, Dhillon-Smith R, Coomarasamy A. Prevalence of adenomyosis in women with subfertility: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023;62(1):23-41. [Crossref]  [PubMed] 
  21. Abu Hashim H, Elaraby S, Fouda AA, Rakhawy ME. The prevalence of adenomyosis in an infertile population: a cross-sectional study. Reprod Biomed Online. 2020;40(6):842-50. [Crossref]  [PubMed] 
  22. Raffone A, Seracchioli R, Raimondo D, Maletta M, Travaglino A, Raimondo I, et al. Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(1):47-53. [Crossref]  [PubMed]  [PMC] 
  23. Di Donato N, Montanari G, Benfenati A, Leonardi D, Bertoldo V, Monti G, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;181:289-93. [Crossref]  [PubMed] 
  24. Kristen U, Stacey M. Epidemiology of Adenomyosis. Semin Reprod Med 2020;38(02/03):89-107. [Crossref]  [PubMed]  [PMC] 
  25. Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G, Taniguchi F. The Impact of Adenomyosis on Women's Fertility. Obstet Gynecol Surv. 2016;71(9):557-68. [Crossref]  [PubMed]  [PMC] 
  26. Schindler AE. Hormonal contraceptives and endometriosis/adenomyosis. Gynecol Endocrinol. 2010;26(12):851-4. [Crossref]  [PubMed] 
  27. Etrusco A, Barra F, Chiantera V, Ferrero S, Bogliolo S, Evangelisti G, et al. Current Medical Therapy for Adenomyosis: From Bench to Bedside. Drugs. 2023;83(17):1595-611. [Crossref]  [PubMed]  [PMC] 
  28. Chen S, Wang J, Sun W, Zhu L, He J, Zhang X. Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study. Ann Transl Med. 2020;8(21):1356. [Crossref]  [PubMed]  [PMC] 
  29. Abbas AM, Samy A, Atwa K, Ghoneim HM, Lotfy M, Saber Mohammed H, et al. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies. Acta Obstet Gynecol Scand. 2020;99(5):571-81. [Crossref]  [PubMed] 
  30. Hahn RA, Truman BI. Education Improves Public Health and Promotes Health Equity. Int J Health Serv. 2015;45(4):657-78. [Crossref]  [PubMed]  [PMC] 
  31. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod. 1997;12(6):1275-9. [Crossref]  [PubMed] 
  32. Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P, Gise. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):103-6 [Crossref]  [PubMed] 
  33. Udry JR. Age at menarche, at first intercourse, and at first pregnancy. J Biosoc Sci. 1979;11(4):433-41. [Crossref]  [PubMed] 
  34. Baird DD. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol. 2004;159(2):124-6. [Crossref]  [PubMed] 
  35. Vercellini P, Parazzini F, Oldani S, Panazza S, Bramante T, Crosignani PG. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod. 1995;10(5):1160-2. [Crossref]  [PubMed] 
  36. Pijnenborg R The human decidua as a passage-way for trophoblast invasion: A review. Trophoblast Research. 1998;11:229-241 [Crossref] 
  37. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001;16(11):2418-21. [Crossref]  [PubMed] 
  38. Trabert B, Weiss NS, Rudra CB, Scholes D, Holt VL. A case-control investigation of adenomyosis: impact of control group selection on risk factor strength. Womens Health Issues. 2011;21(2):160-4 . [Crossref]  [PubMed]  [PMC] 
  39. Riggs JC, Lim EK, Liang D, Bullwinkel R. Cesarean section as a risk factor for the development of adenomyosis uteri. J Reprod Med. 2014; 59:20-4.
  40. Sowers MR, Zheng H, McConnell D, Nan B, Harlow SD, Randolph JF Jr., Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab. 2008;93(10):3847-52. [Crossref]  [PubMed]  [PMC] 
  41. Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril. 2008;90(2):415-24. [Crossref]  [PubMed]  [PMC] 
  42. Chen Q, Li YW, Wang S, Fan QB, Shi HH, Leng JH, et al. Clinical Manifestations Of Adenomyosis Patients With Or Without Pain Symptoms. J Pain Res. 2019;12:3127-33. [Crossref]  [PubMed]  [PMC] 
  43. Bodur S, Dundar O, Pektas MK, Babayigit MA, Ozden O, Kucukodaci Z. The clinical significance of classical and new emerging determinants of adenomyosis. Int J Clin Exp Med. 2015;8(5):7958-64.
  44. Ajao MO, Oliveira Brito LG, Wang KC, et al. Persistence of Symptoms After Total vs Supracervical Hysterectomy in Women with Histopathological Diagnosis of Adenomyosis. J Minim Invasive Gynecol. 2019;26(5):891-6. [Crossref]  [PubMed]